Argent BioPharma Ltd.

A clinical-stage biopharmaceutical company focused on developing and marketing innovative drugs using nanotechnology and a multidisciplinary approach.

Biotechnology & Medical Research
public
Subiaco, Australia Founded 2015
Last updated 2026-09-02
Total raised
—
Stage
—
Founded
2015
Headcount
3
HQ
Subiaco, Australia
Sector
Biotechnology & Medical Research

About

Argent BioPharma Ltd. is a clinical-stage biopharmaceutical company that develops nano-engineered therapeutics to reset the balance between the nervous and immune systems. The company focuses on addressing unmet medical needs, particularly in the central nervous system (CNS) and autoimmune system, through its in-house R&D platform. Its product candidates include CannEpil for refractory epilepsy, CimetrA for acute lung injury and ARDS, and CogniCann for dementia and Alzheimer's patients. The company rebranded from MGC Pharmaceuticals in March 2026.

Headcount over time

3 employees (2026-09) · 1 point
3 3 2026-09

Offices

Subiaco, Australia · HQ / main office

Q&A

What is Argent BioPharma Ltd.'s primary focus?
Argent BioPharma Ltd. is a clinical-stage biopharmaceutical company focused on developing nano-engineered therapeutics to balance the nervous and immune systems, addressing unmet medical needs in the central nervous system (CNS) and autoimmune system.
What are some of Argent BioPharma Ltd.'s key product candidates?
Argent BioPharma Ltd.'s product candidates include CannEpil for refractory epilepsy, CimetrA for acute lung injury and ARDS, and CogniCann for dementia and Alzheimer's patients.
When was Argent BioPharma Ltd. founded?
Argent BioPharma Ltd. was founded in 2015.
What was Argent BioPharma Ltd. formerly known as?
Argent BioPharma Ltd. rebranded from MGC Pharmaceuticals in March 2026.
Where is Argent BioPharma Ltd. headquartered?
Argent BioPharma Ltd. is headquartered in Subiaco, Australia.
Who is the Chief Executive Officer and Managing Director of Argent BioPharma Ltd.?
Roby Reuven Zomer is the Director, Chief Executive Officer and Managing Director of Argent BioPharma Ltd., appointed in 2025.
What core technologies does Argent BioPharma Ltd. utilize?
Argent BioPharma Ltd. utilizes nanotechnology and polypharmacology as its core technologies.
Which sectors does Argent BioPharma Ltd. operate in?
Argent BioPharma Ltd. operates in the Healthcare and Biotechnology & Pharmaceuticals sectors, with a primary focus on Biotechnology.

Team · 8

Roby Reuven Zomer
Founder · Co-Founder, MD, CEO & Chairman
Andrew Chapman
Executive Director
Ross Grant Thomas Walker
Chairman of Strategic Advisory Board
Uri Kramer
Member of Strategic Advisory Board
Wendyl D'Souza
Member of Medical Advisory Board
Daniel Robinson
Non-Executive Independent Director
Shlomo Sadoun
Member of Advisory Board
Rowan Harland
Company Secretary

Sectors & technology

Primary sector
Biotechnology & Medical Research
Technologies
Target customers
Business model
Drug DevelopmentLicensing
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteargentbiopharma.com

Identifiers & details

Legal nameArgent BioPharma Limited
Founded2015
Employees (exact)3